Oxygenta Pharmaceutical Limited (BOM:524636)

India flag India · Delayed Price · Currency is INR
108.45
-4.50 (-3.98%)
At close: Jul 14, 2025
237.43%
Market Cap3.91B
Revenue (ttm)1.09B
Net Income (ttm)-102.98M
Shares Out36.98M
EPS (ttm)-2.86
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,208
Average Volume3,880
Open118.00
Previous Close112.95
Day's Range108.00 - 118.00
52-Week Range30.00 - 133.50
Beta0.50
RSI39.08
Earnings DateAug 13, 2025

About Oxygenta Pharmaceutical

Oxygenta Pharmaceutical Limited manufactures and sells bulk drugs and active pharmaceutical ingredients in India. The company offers pharmaceutical preparation and organic fine chemicals. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1990
Employees 161
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524636
Full Company Profile

Financial Performance

In 2024, Oxygenta Pharmaceutical's revenue was 1.09 billion, an increase of 175.71% compared to the previous year's 396.42 million. Losses were -102.98 million, 196.0% more than in 2023.

Financial Statements

News

There is no news available yet.